PM · Philip Morris International Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| E-vapor shipment volume | 1.3B | the three months ended June 30, 2026 filing | — |
| Estimated industry volume growth (excluding China and the U.S.) for cigarettes and HTUs | 0.8% | the three months ended June 30, 2026 filing | — |
| HTU adjusted IMS volume growth | 5.1% | the three months ended June 30, 2026 filing | — |
| HTU shipment volume | 41.8B | the three months ended June 30, 2026 filing | — |
| International Combustibles cigarette category volume share | 25.3% | the three months ended June 30, 2026 filing | — |
| International Combustibles cigarette shipment volume | 156.9B | the three months ended June 30, 2026 filing | — |
| International Smoke-Free shipment volume | 44.7B | the three months ended June 30, 2026 filing | — |
| Marlboro category share | 11% | the three months ended June 30, 2026 filing | — |
| Modern oral volume | 0.6B | the three months ended June 30, 2026 filing | — |
| Modern oral volume growth | 14.7% | the three months ended June 30, 2026 filing | — |
| Oral SFP shipment volume | 5.1B | the three months ended June 30, 2026 filing | — |
| restructuring charges | $6M | For the Three Months Ended June 30, 2026 filing | — |
| Smoke-Free Products shipment volume | 48.2B | the three months ended June 30, 2026 filing | — |
| Total shipment volume | 205.2B | the three months ended June 30, 2026 filing | — |
| U.S. oral smoke-free products shipment volume | 3.5B | the second quarter filing | — |
| VEEV shipment volume growth | 55.1% | the three months ended June 30, 2026 filing | — |
| ZYN shipments | 2.9B | the second quarter filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Tobacco — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PM
this stock
Philip Morris International Inc.
|
$296.88B | +16.9% | +7.3% | 27.4 | 0.9% |
|
BTI
British American Tobacco p.l.c.
|
$118.02B | -7.0% | — | — | 0.1% |
|
MO
Altria Group, Inc.
|
$114.91B | +16.8% | -3.1% | 14.5 | 2.3% |
|
RLX
RLX Technology Inc.
|
$2.05B | -26.6% | +50.3% | — | 0.8% |
|
TPB
Turning Point Brands, Inc.
|
$1.24B | -48.7% | +28.4% | 20.0 | 15.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PM | -1.6% | +0.7% | +15.2% | -1.8% | +16.9% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -1.4% | +1.2% | +3.0% | -2.7% | +4.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.